Genetics of Renal End Organ Damage in Hypertension

高血压肾终末器官损伤的遗传学

基本信息

  • 批准号:
    8477235
  • 负责人:
  • 金额:
    $ 35.23万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-08-01 至 2015-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Abstract There is an alarming increase in the incidence of end-stage renal disease in the Unites States, with hypertension and diabetes being the major cause. Currently, 25.6 million people are in the early phase of kidney disease (stage 1 to 3) and while strict control of blood pressure and glucose levels may slow, it will not prevent the progressive decline of renal function in these patients. Therefore, understanding the genetic basis of hypertension-induced renal disease is of considerable interest. Significant progress has been made to identify the genetic causes of familial forms of renal disease (nephrotic syndrome). However, no genetic variants have been found to be causally linked to common forms of renal disease. It is our goal to develop a better understanding of the genetic basis of hypertension-induced renal disease observed in the Dahl salt- sensitive (S) rat, which exhibits significant proteinuria and focal segmental glomerulosclerosis (FSGS). An initial genetic analysis for proteinuria and renal injury was performed using a population derived from the S. The study identified ten genomic regions linked to renal damage (measured by proteinuria) and/or function. A congenic strain developed on chromosome 2 exhibited significantly less proteinuria and FSGS. This proposal will evaluate the hypothesis that genetic variant(s) located to a small region on rat chromosome 2 play a significant role in the progressive FSGS and proteinuria observed in the S rat. Based on congenic strain analysis, the causative locus has been narrowed to <1.2 Mbs containing 27 genes. However, cross-species comparative, inbred-based SNP analysis, comprehensive coding sequence and gene expression analysis has convincingly identified 4 genes for further study. The aims of the proposed study are: (1) to perform temporal studies of blood pressure and renal hemodynamics, including renal blood flow, glomerular capillary pressure, and glomerular permeability in the S and small congenic strain; (2) to perform comprehensive gene expression, western blot analysis, sequencing, and haplotype analysis for genes narrowed to the small region on rat chromosome 2; and (3) to evaluate the functional significance of identified allelic variants using cell- based and whole-animal approaches. In summary, this proposal will identify and prioritize gene(s) linked to proteinuria and FSGS in the Dahl S model of hypertension-induced renal disease and provide a basis for functional studies, gene validation, and eventually study in human-based populations.
描述(由申请人提供):摘要在美国,终末期肾病的发病率正在惊人地增加,其中高血压和糖尿病是主要原因。目前,有2560万人处于肾脏疾病的早期阶段(1至3期),虽然严格控制血压和血糖水平可能会减缓这些患者的肾功能逐渐下降的速度,但并不能阻止这些患者的肾功能逐渐下降。因此,了解高血压引起的肾脏疾病的遗传基础具有相当大的意义。在确定家族性肾病(肾病综合征)的遗传原因方面已取得重大进展。然而,尚未发现遗传变异与常见形式的肾脏疾病存在因果关系。我们的目标是更好地了解在 Dahl 盐敏感 (S) 大鼠中观察到的高血压诱发的肾病的遗传基础,该大鼠表现出显着的蛋白尿和局灶节段性肾小球硬化 (FSGS)。使用来自 S 的群体进行了蛋白尿和肾损伤的初步遗传分析。该研究确定了与肾损伤(通过蛋白尿测量)和/或功能相关的 10 个基因组区域。在 2 号染色体上发育的同源菌株表现出明显较少的蛋白尿和 FSGS。该提案将评估以下假设:位于大鼠 2 号染色体小区域的遗传变异在 S 大鼠中观察到的进行性 FSGS 和蛋白尿中发挥重要作用。根据同源菌株分析,致病位点已缩小至包含 27 个基因的 <1.2 Mbs。然而,跨物种比较、基于近交的 SNP 分析、综合编码序列和基因表达分析已令人信服地鉴定出 4 个基因可供进一步研究。本研究的目的是:(1) 对 S 型和小同源型菌株的血压和肾血流动力学进行时间研究,包括肾血流量、肾小球毛细血管压力和肾小球通透性; (2)对大鼠2号染色体上的小区域基因进行全面的基因表达、蛋白质印迹分析、测序和单倍型分析; (3) 使用基于细胞和整体动物的方法评估已识别等位基因变异的功能意义。总之,该提案将在高血压诱发的肾病 Dahl S 模型中识别并优先考虑与蛋白尿和 FSGS 相关的基因,并为功能研究、基因验证和最终在人类人群中的研究提供基础。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Pial Vessel-Associated Microglia/Macrophages Increase in Female Dahl-SS/Jr Rats Independent of Pregnancy History.
与妊娠史无关的女性DAHL-SS/JR大鼠的小血管相关小胶质细胞/巨噬细胞增加。
  • DOI:
    10.3390/ijms23063384
  • 发表时间:
    2022-03-21
  • 期刊:
  • 影响因子:
    5.6
  • 作者:
    Warrington JP;Shao Q;Clayton AM;Maeda KJ;Beckett AG;Garrett MR;Sasser JM
  • 通讯作者:
    Sasser JM
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL R GARRETT其他文献

MICHAEL R GARRETT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL R GARRETT', 18)}}的其他基金

Omics, Bioinformatics and Flow Cytometry Core
组学、生物信息学和流式细胞术核心
  • 批准号:
    10630580
  • 财政年份:
    2023
  • 资助金额:
    $ 35.23万
  • 项目类别:
Project 1 - TBD
项目 1 - 待定
  • 批准号:
    10553868
  • 财政年份:
    2023
  • 资助金额:
    $ 35.23万
  • 项目类别:
Molecular Center of Health and Disease
健康与疾病分子中心
  • 批准号:
    10553864
  • 财政年份:
    2023
  • 资助金额:
    $ 35.23万
  • 项目类别:
Core B-Omics and Gene-Editing
核心 B 组学和基因编辑
  • 批准号:
    10553866
  • 财政年份:
    2023
  • 资助金额:
    $ 35.23万
  • 项目类别:
Core A- Administration, Education, and Mentoring
核心 A- 管理、教育和指导
  • 批准号:
    10553865
  • 财政年份:
    2023
  • 资助金额:
    $ 35.23万
  • 项目类别:
Genetic Targets of Hypertension End Organ Damage
高血压终末器官损伤的遗传靶标
  • 批准号:
    10198017
  • 财政年份:
    2018
  • 资助金额:
    $ 35.23万
  • 项目类别:
Genetic Targets of Hypertension End Organ Damage
高血压终末器官损伤的遗传靶标
  • 批准号:
    9920359
  • 财政年份:
    2018
  • 资助金额:
    $ 35.23万
  • 项目类别:
Core C - Genomics, Animal Models and Advanced Phenotyping Core
核心 C - 基因组学、动物模型和高级表型分析核心
  • 批准号:
    10403631
  • 财政年份:
    2013
  • 资助金额:
    $ 35.23万
  • 项目类别:
Core C - Genomics, Animal Models and Advanced Phenotyping Core
核心 C - 基因组学、动物模型和高级表型分析核心
  • 批准号:
    10159921
  • 财政年份:
    2013
  • 资助金额:
    $ 35.23万
  • 项目类别:
Genetics of Renal End Organ Damage in Hypertension
高血压肾终末器官损伤的遗传学
  • 批准号:
    8289584
  • 财政年份:
    2009
  • 资助金额:
    $ 35.23万
  • 项目类别:

相似海外基金

Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 35.23万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
  • 批准号:
    10100360
  • 财政年份:
    2024
  • 资助金额:
    $ 35.23万
  • 项目类别:
    Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
  • 批准号:
    24K04974
  • 财政年份:
    2024
  • 资助金额:
    $ 35.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
  • 批准号:
    23K01686
  • 财政年份:
    2023
  • 资助金额:
    $ 35.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
  • 批准号:
    23K01692
  • 财政年份:
    2023
  • 资助金额:
    $ 35.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
  • 批准号:
    23K01695
  • 财政年份:
    2023
  • 资助金额:
    $ 35.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
  • 批准号:
    23K01713
  • 财政年份:
    2023
  • 资助金额:
    $ 35.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
  • 批准号:
    2312319
  • 财政年份:
    2023
  • 资助金额:
    $ 35.23万
  • 项目类别:
    Standard Grant
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
  • 批准号:
    23K01715
  • 财政年份:
    2023
  • 资助金额:
    $ 35.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
  • 批准号:
    10585388
  • 财政年份:
    2023
  • 资助金额:
    $ 35.23万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了